Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Divestments (2021 - 2023)

Lifecore Biomedical, Inc. \De\ (LFCR) has 3 years of Divestments data on record, last reported at -$15.7 million in Q2 2023.

  • For Q2 2023, Divestments fell 155.16% year-over-year to -$15.7 million; the TTM value through Feb 2024 reached -$15.7 million, down 135.55%, while the annual FY2022 figure was $73.5 million, N/A changed from the prior year.
  • Divestments reached -$15.7 million in Q2 2023 per LFCR's latest filing, down from $12.5 million in the prior quarter.
  • Across five years, Divestments topped out at $45.1 million in Q3 2021 and bottomed at -$45.1 million in Q4 2021.
  • Average Divestments over 3 years is $10.5 million, with a median of $12.5 million recorded in 2023.
  • The widest YoY moves for Divestments: up 72.22% in 2023, down 155.16% in 2023.
  • A 3-year view of Divestments shows it stood at -$45.1 million in 2021, then surged by 106.95% to $3.1 million in 2022, then crashed by 599.71% to -$15.7 million in 2023.
  • Per Business Quant database, its latest 3 readings for Divestments were -$15.7 million in Q2 2023, $12.5 million in Q1 2023, and $3.1 million in Q3 2022.